Stoke Therapeutics Inc.
9.30
0.62 (7.14%)
At close: Jan 15, 2025, 11:08 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -104.70M -101.07M -85.81M -52.24M -32.33M -12.52M -5.56M
Depreciation & Amortization 2.47M 1.55M 974.00K 888.00K 450.00K 214.00K 113.00K
Stock-Based Compensation 25.26M 22.85M 16.45M 5.77M 1.92M 240.00K 26.00K
Other Working Capital -2.82M 42.90M -2.85M -2.88M -2.00M 1.09M 31.00K
Other Non-Cash Items 1.94M 1.78M 1.26M 1.04M 3.00K 10.00K 4.00K
Deferred Income Tax n/a n/a 172.00K 3.00K n/a n/a n/a
Change in Working Capital -6.03M 43.02M 46.00K 2.33M -1.10M 1.09M 31.00K
Operating Cash Flow -81.07M -31.87M -66.91M -42.22M -31.05M -10.96M -5.38M
Capital Expenditures -1.62M -3.96M -1.20M -1.05M -1.64M -935.00K -113.00K
Acquisitions n/a 45.34M 75.23M n/a 1K 10.00K n/a
Purchase of Investments n/a -201.32M -87.23M n/a n/a n/a n/a
Sales Maturities Of Investments 107.56M 159.40M 12.00M n/a n/a n/a n/a
Other Investing Acitivies n/a -45.34M -75.23M n/a 1K 10.00K n/a
Investing Cash Flow 105.95M -45.88M -76.43M -1.05M -1.63M -925.00K -113.00K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 926.00K 1.06M 1.28M 2.71M -2.15M 115.64M 5.97M
Financial Cash Flow 53.01M 46.41M 1.28M 108.11M 149.76M 115.64M 5.97M
Net Cash Flow 77.89M -31.34M -142.05M 64.84M 117.07M 103.75M 477.00K
Free Cash Flow -82.68M -35.83M -68.11M -43.27M -32.69M -11.90M -5.50M